Literature DB >> 30225600

Combining non-contrast and dual-energy CT improves diagnosis of early gout.

Seul Ki Lee1,2, Joon-Yong Jung3, Won-Hee Jee1, Jennifer Jooha Lee4, Sung-Hwan Park4.   

Abstract

OBJECTIVES: To determine the incremental value of non-contrast CT (NCCT) on dual-energy CT (DECT) in symptomatic first metatarsophalangeal (MTP) joints in early gout.
METHODS: One hundred and fifteen painful joints were consecutively enrolled and gout was diagnosed based on the 2015 EULAR/ACR criteria and/or arthrocentesis. Two readers independently evaluated DECT alone and combined NCCT and DECT (NCCT+DECT) based on four semiquantitative scales. Sensitivities and specificities were compared using McNemar's test. AUC was compared.
RESULTS: Of the 115 joints, 72 were defined as an early gout group and 43 as a gout-negative group after exclusion. The sensitivity and specificity for the early gout group on DECT alone were as followed: reader 1 - 52.8% and 100.0% and reader 2 - 51.4% and 100.0%. NCCT+DECT results were as follows: reader 1 - 79.2% and 93.0% and reader 2 - 79.2% and 95.3%. AUC was significantly higher in NCCT+DECT compared to that in DECT alone for the early gout group (0.888 vs. 0.774 for reader 1, p = 0.0004; 0.896 vs. 0.816 for reader 2, p = 0.0142). The false-negative cases on DECT occurred more frequently with the first-onset gout, and tended to be affected by a longer duration of symptoms in the post-hoc analysis.
CONCLUSION: The combined analysis of NCCT and DECT improves diagnostic capabilities in symptomatic early gout involving the first MTP joint. KEY POINTS: • MSU crystal depositions in early gout may be seen on non-contrast CT, while still being undetectable by DECT. • Combining non-contrast CT and DECT improves detection of early gout. • False negatives of DECT are more common than previously reported in cases of first-onset gout.

Entities:  

Keywords:  Dual-energy CT; Gout; Metatarsophalangeal joint; Tomography, x-ray computed; Uric acid

Mesh:

Year:  2018        PMID: 30225600     DOI: 10.1007/s00330-018-5716-4

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  34 in total

1.  Virtual monochromatic imaging in dual-source dual-energy CT: radiation dose and image quality.

Authors:  Lifeng Yu; Jodie A Christner; Shuai Leng; Jia Wang; Joel G Fletcher; Cynthia H McCollough
Journal:  Med Phys       Date:  2011-12       Impact factor: 4.071

2.  Dual energy CT in gout: a prospective validation study.

Authors:  Hyon K Choi; Lindsay C Burns; Kamran Shojania; Nicole Koenig; Graham Reid; Mohammed Abufayyah; Genevieve Law; Alison S Kydd; Hugue Ouellette; Savvas Nicolaou
Journal:  Ann Rheum Dis       Date:  2012-03-02       Impact factor: 19.103

3.  False-negative dual-energy computed tomography in a patient with acute gout.

Authors:  Katrina N Glazebrook; Sanjeev Kakar; Cristiane M Ida; Javier A Laurini; Kevin G Moder; Shuai Leng
Journal:  J Clin Rheumatol       Date:  2012-04       Impact factor: 3.517

4.  Identification of intraarticular and periarticular uric acid crystals with dual-energy CT: initial evaluation.

Authors:  Katrina N Glazebrook; Luis S Guimarães; Naveen S Murthy; David F Black; Tim Bongartz; Nisha J Manek; Shuai Leng; Joel G Fletcher; Cynthia H McCollough
Journal:  Radiology       Date:  2011-09-16       Impact factor: 11.105

5.  Cellular characterization of the gouty tophus: a quantitative analysis.

Authors:  Nicola Dalbeth; Bregina Pool; Greg D Gamble; Timothy Smith; Karen E Callon; Fiona M McQueen; Jillian Cornish
Journal:  Arthritis Rheum       Date:  2010-05

6.  Image quality optimization and evaluation of linearly mixed images in dual-source, dual-energy CT.

Authors:  Lifeng Yu; Andrew N Primak; Xin Liu; Cynthia H McCollough
Journal:  Med Phys       Date:  2009-03       Impact factor: 4.071

Review 7.  Update on gout: new therapeutic strategies and options.

Authors:  Robert Terkeltaub
Journal:  Nat Rev Rheumatol       Date:  2010-01       Impact factor: 20.543

8.  Dual energy computed tomography in tophaceous gout.

Authors:  H K Choi; A M Al-Arfaj; A Eftekhari; P L Munk; K Shojania; G Reid; S Nicolaou
Journal:  Ann Rheum Dis       Date:  2008-12-09       Impact factor: 19.103

Review 9.  Gout--what are the treatment options?

Authors:  Naomi Schlesinger; Nicola Dalbeth; Fernando Perez-Ruiz
Journal:  Expert Opin Pharmacother       Date:  2009-06       Impact factor: 3.889

Review 10.  Gout: a clinical and radiologic review.

Authors:  Johnny U V Monu; Thomas L Pope
Journal:  Radiol Clin North Am       Date:  2004-01       Impact factor: 2.303

View more
  5 in total

1.  Development and validation of a quantitative method for estimation of the urate burden in patients with gouty arthritis using dual-energy computed tomography.

Authors:  Maximilian Kotlyarov; Kay Geert A Hermann; Jürgen Mews; Bernd Hamm; Torsten Diekhoff
Journal:  Eur Radiol       Date:  2019-07-22       Impact factor: 5.315

2.  Optimization of dual energy computed tomography post-processing to reduce lower limb artifacts in gout.

Authors:  Baptiste Dubief; Julien Avril; Tristan Pascart; Marie Schmitt; Romaric Loffroy; Jean-Francis Maillefert; Paul Ornetti; André Ramon
Journal:  Quant Imaging Med Surg       Date:  2022-01

Review 3.  Gouty Arthropathy: Review of Clinical Manifestations and Treatment, with Emphasis on Imaging.

Authors:  Jennifer S Weaver; Ernest R Vina; Peter L Munk; Andrea S Klauser; Jamie M Elifritz; Mihra S Taljanovic
Journal:  J Clin Med       Date:  2021-12-29       Impact factor: 4.241

4.  A novel parameter derived from post-processing procedure of dual energy CT for identification of gout.

Authors:  Chunlin Xiang; Hongyan Zhang; Gang Wu
Journal:  Sci Rep       Date:  2021-11-03       Impact factor: 4.379

5.  Gout of feet and ankles in different disease durations: diagnostic value of single-source DECT and evaluation of urate deposition with a novel semi-quantitative DECT scoring system.

Authors:  Jin Shang; Xiao-Hu Li; Shu-Qin Lu; Yi Shang; Lu-Lu Li; Bin Liu
Journal:  Adv Rheumatol       Date:  2021-06-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.